AssetMark Inc
IDYA icon

AssetMark Inc’s IDEAYA Biosciences IDYA Stock Holding History

AssetMark Inc’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.43M Sell
63,313
-1,708
-3% -$64.5K ﹤0.01% 902
2026
Q2 		$2.42M Sell
65,021
-611
-0.9% -$18.7K ﹤0.01% 906
2026
Q1 		$2.19M Sell
65,632
-6,305
-9% -$212K ﹤0.01% 869
2025
Q4 		$2.49M Sell
71,937
-4,306
-6% -$137K 0.01% 803
2025
Q3 		$2.07M Buy
76,243
+13,657
+22% +$330K ﹤0.01% 805
2025
Q2 		$1.32M Buy
62,586
+12,836
+26% +$246K ﹤0.01% 863
2025
Q1 		$815K Buy
49,750
+4,481
+10% +$95.5K ﹤0.01% 897
2024
Q4 		$1.16M Buy
45,269
+1,084
+2% +$30.7K ﹤0.01% 819
2024
Q3 		$1.4M Buy
44,185
+4,481
+11% +$170K ﹤0.01% 727
2024
Q2 		$1.39M Buy
39,704
+14,013
+55% +$555K ﹤0.01% 694
2024
Q1 		$1.13M Buy
+25,691
New +$1.1M ﹤0.01% 704

Other funds holding IDYA

General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

AssetMark Inc's IDYA Position: Q3 2026 in Review

AssetMark Inc reduced its IDEAYA Biosciences (IDYA) stake by 2.6% in Q3 2026, selling an estimated $64.5K and leaving 63,313 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #902.

AssetMark Inc first reported a position in IDYA in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.49M in Q4 2025. 64 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • AssetMark Inc held 63,313 shares of IDEAYA Biosciences worth $2.43M as of Q3 2026.
  • AssetMark Inc sold 1,708 IDEAYA Biosciences shares in Q3 2026, an estimated $64.5K.
  • IDEAYA Biosciences made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #902 holding.
  • AssetMark Inc first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 11 quarters since.
  • AssetMark Inc's IDEAYA Biosciences position peaked at $2.49M in Q4 2025.
  • 64 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.